Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $308.15 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $123.63 | 1 | $0 (2022) |
| Novo Nordisk Inc | $107.27 | 7 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $45.64 | 3 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.48 | 1 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $15.13 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $274.96 | 11 | SANOFI-AVENTIS U.S. LLC ($123.63) |
| 2021 | $33.19 | 2 | Novo Nordisk Inc ($33.19) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/15/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $123.63 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/07/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/15/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Diabetes | ||||||
| 07/14/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Diabetes | ||||||
| 06/09/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $15.13 | General |
| Category: Pain Management | ||||||
| 04/08/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV | Food and Beverage | In-kind items and services | $16.48 | General |
| 04/07/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/31/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Diabetes | ||||||
| 02/22/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 02/16/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/26/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Diabetes | ||||||
| 09/22/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Diabetes | ||||||
| 08/19/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Diabetes | ||||||
About Sylvia Windham, CNM
Sylvia Windham, CNM is a Advanced Practice Midwife healthcare provider based in Mendenhall, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2014. The National Provider Identifier (NPI) number assigned to this provider is 1811309040.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sylvia Windham, CNM has received a total of $308.15 in payments from pharmaceutical and medical device companies, with $274.96 received in 2022. These payments were reported across 13 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($308.15).
Practice Information
- Specialty Advanced Practice Midwife
- Other Specialties Family
- Location Mendenhall, MS
- Active Since 05/22/2014
- Last Updated 08/27/2021
- Taxonomy Code 367A00000X
- Entity Type Individual
- NPI Number 1811309040
Products in Payments
- TOUJEO (Biological) $123.63
- Rybelsus (Drug) $60.17
- ENTRESTO (Drug) $45.64
- Ozempic (Drug) $33.17
- Seglentis (Drug) $15.13
- RYBELSUS (Drug) $13.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.